Obesity: Health costs estimated at $75 billion

August 2006
Drug Store News;8/28/2006, Vol. 28 Issue 10, p50
Trade Publication
The article provides an overview of the anti-obesity drug market in the United States. Data showed that 32 percent of American adults are obese, which represents more than 60 percent increase in the prevalence of obesity since 1993. Overweight and obesity are associated with an increased risk of developing hypertension, type 2 diabetes and heart disease. Roche's Xenical and Abbott's Meridia are the leading anti-obesity drugs in the market.


Related Articles

  • Drug chains eye opportunity to fatten up OTC diet sales. Eder, Rob // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP31 

    Focuses on the growth of the over-the-counter (OTC) diet products category in the United States. Merchandising limitations of the category; HealthRite's launch of an OTC version of its doctor-directed MediFast diet program; Merchandising efforts in the liquid/powder segment; Leadership of...

  • Diet category growth expected as consumer preferences shift. Beezer, Elizabeth // Drug Store News;12/14/98, Vol. 20 Issue 20, pCP31 

    Forecasts the growth of the over-the-counter (OTC) diet products market in the United States. Factors that guarantee the long-term stability of the weight loss category; Growth prospects for weight-reducing meal replacement products; Performance of the weight-loss capsules and tablets category.

  • News you can use.  // Pharmacy Today;Dec2010, Vol. 16 Issue 12, p1 

    The article offers news briefs related to the pharmaceutical industry in the U.S. A study by physician Ruth Klaasen and colleagues found that some arthritis drugs such as infliximab are less effective for obese patients. Xanodyne Pharmaceuticals Inc. has agreed to withdraw propoxyphene from the...

  • Dieters ready for more ready-to-eat/drink formulas. Eder, Rob // Drug Store News;2/1/99, Vol. 21 Issue 2, p23 

    Provides information on the growth of over-the-counter diet/weight loss products at retail outlets of drug chains in the United States. Strength of the products in the market; How consumers view the diet/weight loss products; Top brands in diet/weight loss liquids and powders.

  • Doctor sues for unfair dismissal claiming Roche feared she would blow the whistle. Brettingham, Madeleine // BMJ: British Medical Journal (International Edition);2/25/2006, Vol. 332 Issue 7539, p441 

    The article discusses the dismissal of doctor Ryta Kuzel, former head of British regulatory affairs at the pharmaceutical company Roche Products. Kuzel claims that her termination was unfair and is suing the company. She was allegedly terminated to keep her quiet when she discovered corrupt...

  • Obesity drugs trim ads. Goetzl, David // Advertising Age;8/13/2001, Vol. 72 Issue 33, p10 

    The article reports on the decision of obesity drug manufacturers Hoffmann-La Roche and Abbott Pharmaceuticals to discontinue direct-to-consumer (DTC) advertising for their products. Hoffmann-La Roche's new campaign, launched in February 2001, which was designed in part to divert attention from...

  • Chewing the fat over the reality of obesity. Boddy, Gail // Nutridate;Jul2011, Vol. 22 Issue 3, p8 

    The article focuses on the efforts of health professionals and academics to challenge the myths regarding the obesity epidemic. Health sociologists argued that claims have been made by some research bodies to justify the need for more funding or to market products and services, specially those...

  • SERVICIOS PARA PERSONAS CON SOBREPESO. FERNÁNDEZ, DIANA // Entrepreneur Mexico;sep2009, Vol. 17 Issue 9, p76 

    No abstract available.

  • Getting Ahead of the Curve: Satiety. Sloan, A. Elizabeth // Nutraceuticals World;Dec2010, Vol. 13 Issue 10, p16 

    The article focuses on the food-based solutions that can potentially corner the weight loss market. It states that the solutions can serve as a viable market among health food channels and health conscious consumers and increase medical counts leading to satiety for commercialization. It also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics